Headquartered in Needham, MA, Invicro, a subsidiary of REALM IDx, was founded in 2008 with the mission of improving the role and function of imaging in translational drug discovery and development. Today, Invicro’s multi-disciplinary team provides solutions to pharmaceutical and biotech companies across all stages of the drug development pipeline (Preclinical through Phase 0-IV), all imaging modalities and all therapeutic areas. Invicro’s quantitative biomarker services, pathology solutions, advanced analytics and AI tools, and clinical operational services are backed by Invicro’s industry-leading software informatics platforms, VivoQuant® and iPACS®, as well as their pioneering IQ Analytics Platform, which includes Amyloid-IQ, Tau-IQ and DaT-IQ.
Invicro operates out of nine global laboratories, clinics and sites within the United States in Massachusetts, Michigan, California, Connecticut and globally in the United Kingdom, India, Japan and China.
Learn more by visiting www.invicro.com
Site |
Badges |
|
Invicro LLC
115 4th Ave
Needham, MA, 02494
United States
|
|
|
APS CAP/CLIA Lab
1 Enterprise, Suite 1F
Aliso Viejo, California, 92656
United States
|
|
|
Imanova Ltd
Burlington Danes Building
London, , W12 0NN
United Kingdom
|
|
|
Invicro, Molecular Imaging Center (MIC)
Sanford Consortium for Regenerative Medicine
La Jolla, California, 92037
United States
|
|
|
Invicro LLC
Richard Coelho
Durham, NC, 27709
United States
|
|
|
Invicro LLC
119 Fourth Ave
Needham, MA, 02494
United States
|
|
|
Imanova Ltd, Trading as Invicro
Burlington Danes Building
London, , W12 0NN
United Kingdom
|
|
|
Invicro
60 Temple Street
New Haven, CT, 06510
United States
|
|